46,183 Shares in The Allstate Corporation $ALL Bought by Daiichi Life Insurance Co. Ltd.

Daiichi Life Insurance Co. Ltd. bought a new stake in The Allstate Corporation (NYSE:ALL) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 46,183 shares of the insurance provider’s stock, valued at approximately $10,989,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ALL. Brighton Jones LLC boosted its stake in shares of Allstate by 60.2% during the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after buying an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC acquired a new stake in shares of Allstate in the fourth quarter valued at about $231,000. WINTON GROUP Ltd bought a new stake in Allstate during the second quarter worth about $210,000. Treasurer of the State of North Carolina raised its holdings in Allstate by 2.5% during the second quarter. Treasurer of the State of North Carolina now owns 123,272 shares of the insurance provider’s stock worth $24,816,000 after acquiring an additional 3,051 shares in the last quarter. Finally, Ieq Capital LLC boosted its position in Allstate by 20.1% during the second quarter. Ieq Capital LLC now owns 38,316 shares of the insurance provider’s stock valued at $7,713,000 after purchasing an additional 6,412 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Key Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ALL shares. Barclays boosted their target price on shares of Allstate from $213.00 to $226.00 and gave the stock an “underweight” rating in a report on Thursday, August 6th. Roth Capital set a $300.00 price target on shares of Allstate in a research note on Thursday, August 6th. Cantor Fitzgerald lifted their price objective on shares of Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Citigroup lowered shares of Allstate from a “neutral” rating to a “sell” rating and boosted their price objective for the stock from $226.00 to $240.00 in a research note on Tuesday, August 11th. Finally, Wells Fargo & Company cut shares of Allstate from an “equal weight” rating to an “underweight” rating and upped their target price for the company from $243.00 to $250.00 in a report on Friday, August 7th. Four investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Allstate has a consensus rating of “Hold” and an average price target of $265.26.

Insider Transactions at Allstate

In related news, Director Andrea Redmond sold 2,225 shares of Allstate stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $202.91, for a total transaction of $451,474.75. Following the completion of the sale, the director directly owned 2,225 shares of the company’s stock, valued at approximately $451,474.75. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This trade represents a 40.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 91,446 shares of company stock worth $24,208,675 over the last quarter. Company insiders own 1.55% of the company’s stock.

Allstate Price Performance

NYSE:ALL opened at $253.82 on Friday. The Allstate Corporation has a one year low of $188.08 and a one year high of $277.22. The company has a market cap of $64.18 billion, a P/E ratio of 5.07, a P/E/G ratio of 0.39 and a beta of 0.16. The firm’s fifty day moving average price is $250.34 and its two-hundred day moving average price is $224.95. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. Allstate’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the company posted $5.94 EPS. Equities analysts expect that The Allstate Corporation will post 34.45 earnings per share for the current year.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Monday, August 31st. Allstate’s payout ratio is currently 8.63%.

Allstate Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.